Profound Medical Corp.
PROF- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001628808
No open-market purchases or sales by Profound Medical Corp. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $105.8M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Profound Medical Corp. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 46 | 44 | −2 |
| Shares | 9.78M | 9.40M | −372.0K (−3.8%) |
| Value | $109.8M | $84.6M | −$25.1M (−22.9%) |
New holders (4)
Institutions that held Profound Medical Corp. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Wealth Management Partners, LLC | 26,000 | $230.0K | 0.16% |
| Jane Street Group, LLC | 14,747 | $132.0K | 0.00% |
| Aquatic Capital Management LLC | 200 | $2.00K | 0.00% |
| Parallel Advisors, LLC | 30 | $0 | 0.00% |
Sold out (6)
Institutions that held Profound Medical Corp. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Anson Funds Management LP | 34,406 | $388.0K |
| Susquehanna International Group, LLP | 33,496 | $376.0K |
| Citadel Advisors LLC | 33,343 | $374.0K |
| Wolverine Trading, LLC | 10,811 | $128.0K |
| UBS Group AG | 1,428 | $16.0K |
| Bessemer Group Inc | 165 | $2.00K |